Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $58.89 million. The enterprise value is -$56.98 million.

Market Cap	58.89M
Enterprise Value	-56.98M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ACRV has 38.74 million shares outstanding. The number of shares has increased by 13.96% in one year.

Current Share Class	38.74M
Shares Outstanding	38.74M
Shares Change (YoY)	+13.96%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	6.73%
Owned by Institutions (%)	31.16%
Float	25.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	32.96
PB Ratio	0.43
P/TBV Ratio	0.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.69, with a Debt / Equity ratio of 0.02.

Current Ratio	7.69
Quick Ratio	7.57
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.86% and return on invested capital (ROIC) is -35.56%.

Return on Equity (ROE)	-53.86%
Return on Assets (ROA)	-32.22%
Return on Invested Capital (ROIC)	-35.56%
Return on Capital Employed (ROCE)	-73.75%
Weighted Average Cost of Capital (WACC)	13.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	76
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.52% in the last 52 weeks. The beta is 1.74, so ACRV's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	-9.52%
50-Day Moving Average	1.64
200-Day Moving Average	1.75
Relative Strength Index (RSI)	47.54
Average Volume (20 Days)	594,874

Short Selling Information

The latest short interest is 2.41 million, so 6.21% of the outstanding shares have been sold short.

Short Interest	2.41M
Short Previous Month	2.14M
Short % of Shares Out	6.21%
Short % of Float	9.38%
Short Ratio (days to cover)	2.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-84.11M
Pretax Income	-77.91M
Net Income	-77.91M
EBITDA	-82.76M
EBIT	-84.11M
Earnings Per Share (EPS)	-$2.02

Balance Sheet

The company has $118.58 million in cash and $2.71 million in debt, with a net cash position of $115.87 million or $2.99 per share.

Cash & Cash Equivalents	118.58M
Total Debt	2.71M
Net Cash	115.87M
Net Cash Per Share	$2.99
Equity (Book Value)	112.52M
Book Value Per Share	3.56
Working Capital	104.78M

Cash Flow

In the last 12 months, operating cash flow was -$63.67 million and capital expenditures -$1.67 million, giving a free cash flow of -$65.33 million.

Operating Cash Flow	-63.67M
Capital Expenditures	-1.67M
Depreciation & Amortization	1.36M
Net Borrowing	n/a
Free Cash Flow	-65.33M
FCF Per Share	-$1.69

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.96%
Shareholder Yield	n/a
Earnings Yield	-132.29%
FCF Yield	-110.94%

Analyst Forecast

The average price target for ACRV is $11.67, which is 667.76% higher than the current price. The consensus rating is "Buy".

Price Target	$11.67
Price Target Difference	667.76%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1